Hamina J. Patel
Keine laufenden Positionen mehr
Profil
Hamina J.
Patel worked as a Director of Drug Development at Johnson & Johnson Ltd., a Principal at Celltech Group Plc, a Chief Medical Officer at Evgen Pharma Plc, a Principal at Chugai Pharma U.K.
Ltd., and a Vice President of Clinical Development at Akamis Bio Ltd.
Ehemalige bekannte Positionen von Hamina J. Patel
| Unternehmen | Position | Ende |
|---|---|---|
| THERACRYF PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Chugai Pharma U.K. Ltd.
 Chugai Pharma U.K. Ltd. Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma U.K. Ltd. is a British pharmaceutical company founded in 1993. The company is based in London, UK and markets pharmaceutical products. | Corporate Officer/Principal | - |
Johnson & Johnson Ltd.
 Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987. | Corporate Officer/Principal | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERACRYF PLC | Health Services |
| Private Unternehmen | 4 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Johnson & Johnson Ltd.
Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987. | Consumer Non-Durables |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Chugai Pharma U.K. Ltd.
Chugai Pharma U.K. Ltd. Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma U.K. Ltd. is a British pharmaceutical company founded in 1993. The company is based in London, UK and markets pharmaceutical products. | Distribution Services |
